| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |